Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-06

FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis Pharma's supplemental approval for the clotrimazole and betamethasone dipropionate topical product. The action approves changes described i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole and betamethasone dipropionate (clotrimazole and betamethasone dipropionate)

Snippet

SUPPL AP for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)